Concepedia

Holland C. Detke

HC

Statistics

Publications

33

Citations

2.7K

H-Index

22

Active since

2003

Affiliations

Eli Lilly (United States)(Current)

McLean Hospital

Harvard University

Universitat Autònoma de Barcelona

University of Minnesota Medical Center

Holland C. Detke is an author at Eli Lilly (United States) specializing in pharmacotherapy, clinical pharmacology, and pharmacy.

Publications per year

2003–2023

33

Publications

33

Galcanezumab in chronic migraine

Holland C. Detke, Peter J. Goadsby, Shufang Wang et al. · Neurology · 2018 · 578 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Randomized, Placebo-Controlled Trial of Olanzapine as Maintenance Therapy in Patients With Bipolar I Disorder Responding to Acute Treatment With Olanzapine

Mauricio Tohen, Joseph R. Calabrese, Michael Banov et al. · American Journal of Psychiatry · 2006 · 316 citations

Medicine, Pharmacotherapy, Psychiatry +14

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Wim M. Mulleners, Byung‐Kun Kim, Miguel J. A. Láinez et al. · The Lancet Neurology · 2020 · 283 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia

John M. Kane, Holland C. Detke, Dieter Naber et al. · American Journal of Psychiatry · 2009 · 197 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Dose correspondence between olanzapine long-acting injection and oral olanzapine

Holland C. Detke, Fangyi Zhao, Parag Garhyan et al. · International Clinical Psychopharmacology · 2010 · 185 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

1–5 of 33